康耐視 CGNX 深 滬
等待開盤 12-13 09:30:00 美东时间
35.83
-1.050
-2.85%
華盛通- 最 高37.2212
- 今 開36.96
- 成交量 146.92万股
- 最 低 35.34
- 昨 收 36.88
- 總市值 60.19亿
- 52周最高 49.675
- 市盈率 靜 58.25
- 換手率 0.87%
- 52周最低 22.425
- 委 比 -41.10%
- 總股本 1.68亿
- 歷史最高 100.395
- 量 比 0.95
- 振 幅 5.10%
- 歷史最低 7.84
- 每 手 1
- 風險率 6.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
12-04 09:38
JP Morgan Downgrades Cognex to Underweight, Lowers Price Target to $35
JP Morgan analyst Tomohiko Sano downgrades Cognex (NASDAQ:CGNX) from Neutral to Underweight and lowers the price target from $45 to $35.
12-03 20:50
SA Asks: What are the best robotics stocks right now?
What are the best robotics stocks right now for investors? Seeking Alpha analysts Michael Del Monte and Julia Ostian offer their picks. Michael Del Monte: Ametek (AME) remains a top pick for robotics ...
11-17 05:01
Cognex Announces Participation at Upcoming Investor Conferences
NATICK, Mass., Nov. 4, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today announced its participation at upcoming invest...
11-04 21:00
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Needham Maintains Buy on Cognex, Raises Price Target to $47
Needham analyst James Ricchiuti maintains Cognex (NASDAQ:CGNX) with a Buy and raises the price target from $45 to $47.
10-31 17:45
Cognex shares are trading lower. The company reported Q3 financial results.
Cognex shares are trading lower. The company reported Q3 financial results.
10-30 23:18
Cognex Sees Q4 Adj EPS $0.19-$0.24 vs $0.22 Est; Sees Sales $230M-$245M vs $236.867M Est
Guidance Cognex issued fourth-quarter 2025 guidance; details are summarized in the table below.As of the date of this release, Cognex continues to expect no material impact on Adjusted Earnings per Share or Adjusted
10-30 04:33
